Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Deals
Features
News
Region
Sectors
Size

$40m-$99.9m

Hydrogenious LOHC fuels up on funding
Erlangen-Nürnberg spinout Hydrogenious LOHC Technologies has added $59m to its coffers.
Vanqua Bio wins over series B investors
Osage University Partners is among the investors in Northwestern spinout Vanqua Bio’s $85m series B round.
TreeFrog dives into $75m series B
The stem cell therapy developer, exploiting research from Digital Photonics and Nanoscience Laboratory, has set up a US subsidiary.
Penn produces iEcure with $50m
Based on technology at University of Pennsylvania, iEcure has launched to commercialise gene therapies initially for liver disorders and an option to license more assets.
Emulate models $82m series E
Harvard spinout Emulate will use the cash to further develop its organ-on-a-chip technology, having now raised nearly $225m in total.
Corelight concentrates $75m into series D
The cybersecurity platform operator has achieved $160m of total funding through a series D round backed by Osage University Partners.
Jeeves adds $57m series B
Stanford-backed expense management platform Jeeves has received series B funding, two months after emerging from stealth.
DNAnudge nabs $60m in series A
Ventura Capital has led the round for the Imperial College London-founded rapid covid-19 test kit maker, which will use the funding to expand internationally.

Other News

Neural Galaxy taps into $77m series A
Harvard and MIT-linked Neural Galaxy has picked up $77m in a series A round led by existing shareholder 3E Bioventures.
Aumni accesses $50m in series B capital
Vanderbilt University has thrown its weight behind the investment analytics provider as it prepares to expand its offering into new customer segments.
MinoSpace takes off with $46m
CAS Star-backed MinoSpace has added $46m in pre-series B funding to its coffers.
Cardior catches $76m series B
Hannover Medical School spinout Cardior has welcomed both new and existing backers, such as Bristol Myers Squibb, for a series B round led by Inkef Capital.
Dice Molecules rolls to $60m series C1
Osage University Partners is among the returning backers that have helped push Stanford-linked Dice Molecules’ total funding to around $200m.
Southchip secures Cash Capital investment
Cash Capital has reinvested in the semiconductor technology developer through a $46.3m series D round.

Editor's Picks

Big deal: Oxford PV begins capturing series D
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Big deal: NMD flexes series A muscles
Aarhus University spinout NMD Pharma, which focuses on therapies for neuromuscular conditions, has attracted the support of several corporates for its $47m series A round.
Big deal: Touchstone helps inject $73m into Cell Medica
Touchstone Innovations, which co-founded the cellular immunotherapy developer in 2007, has contributed to another funding round.
test reg

Login